{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:32:50Z","timestamp":1790508770009,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572336"],"award-info":[{"award-number":["82572336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172041"],"award-info":[{"award-number":["82172041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62405333"],"award-info":[{"award-number":["62405333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"harbin medical university cancer hospital haiyan foundatio"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75422-w","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:45:00Z","timestamp":1784043900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disrupting fumarylacetoacetate hydrolase by stratified nanoplatforms orchestrates metabolic-immune reprogramming and prevents post-ablation HCC relapse"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1173-5615","authenticated-orcid":false,"given":"Zhiwen","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouhan","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-4526","authenticated-orcid":false,"given":"Tengchuang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"75422_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J. Hepatol. 82, 315\u2013374 (2025).","journal-title":"J. Hepatol."},{"key":"75422_CR2","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1200\/JCO.23.02745","volume":"42","author":"JD Gordan","year":"2024","unstructured":"Gordan, J. D. et al. Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline update. J. Clin. Oncol. 42, 1830\u20131850 (2024).","journal-title":"J. Clin. Oncol."},{"key":"75422_CR3","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"75422_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 2, 16018 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"75422_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(24)00731-9","volume":"26","author":"RS Huang","year":"2025","unstructured":"Huang, R. S. et al. Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis. Lancet Oncol. 26, 387\u2013398 (2025).","journal-title":"Lancet Oncol."},{"key":"75422_CR6","doi-asserted-by":"publisher","first-page":"7326","DOI":"10.1021\/acs.chemrev.2c00822","volume":"123","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y. et al. Rational design of biomaterials to potentiate cancer thermal therapy. Chem. Rev. 123, 7326\u20137378 (2023).","journal-title":"Chem. Rev."},{"key":"75422_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","volume":"21","author":"JM Llovet","year":"2024","unstructured":"Llovet, J. M. et al. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 21, 294\u2013311 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"75422_CR8","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1200\/JCO-24-02030","volume":"43","author":"Y Kawaguchi","year":"2025","unstructured":"Kawaguchi, Y. et al. Surgery versus ablation for hepatocellular carcinoma: a randomized controlled trial (SURF-RCT Trial) and a nonrandomized prospective observational trial (SURF-Cohort Trial). J. Clin. Oncol. 43, 2628\u20132638 (2025).","journal-title":"J. Clin. Oncol."},{"key":"75422_CR9","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/hep.26526","volume":"58","author":"S Yoshida","year":"2013","unstructured":"Yoshida, S. et al. Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma. Hepatology 58, 1667\u20131680 (2013).","journal-title":"Hepatology"},{"key":"75422_CR10","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1038\/s41388-018-0169-4","volume":"37","author":"T Su","year":"2018","unstructured":"Su, T. et al. Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. Oncogene 37, 3514\u20133527 (2018).","journal-title":"Oncogene"},{"key":"75422_CR11","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.immuni.2023.05.017","volume":"56","author":"M Vucur","year":"2023","unstructured":"Vucur, M. et al. Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity 56, 1578\u20131595 e1578 (2023).","journal-title":"Immunity"},{"key":"75422_CR12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/hep.31766","volume":"74","author":"T Su","year":"2021","unstructured":"Su, T. et al. Insufficient radiofrequency ablation promotes hepatocellular carcinoma metastasis through N6-methyladenosine mRNA methylation-dependent mechanism. Hepatology 74, 1339\u20131356 (2021).","journal-title":"Hepatology"},{"key":"75422_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500670","volume":"12","author":"Y Ling","year":"2025","unstructured":"Ling, Y. et al. Bimetallic Ca\/Zn nanoagonist remould the immunosuppressive hepatocellular carcinoma microenvironment following incomplete microwave ablation via pyroptosis and the STING signaling pathway. Adv. Sci. 12, e2500670 (2025).","journal-title":"Adv. Sci."},{"key":"75422_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303298","volume":"10","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. Reshaping intratumoral mononuclear phagocytes with antibody-opsonized immunometabolic nanoparticles. Adv. Sci. 10, e2303298 (2023).","journal-title":"Adv. Sci."},{"key":"75422_CR15","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.devcel.2025.02.012","volume":"60","author":"D Zhang","year":"2025","unstructured":"Zhang, D. et al. Glutamine binds HSC70 to transduce signals inhibiting IFN-beta-mediated immunogenic cell death. Dev. Cell 60, 1958\u20131973 e1959 (2025).","journal-title":"Dev. Cell"},{"key":"75422_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jhep.2023.10.024","volume":"80","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism. J. Hepatol. 80, 293\u2013308 (2024).","journal-title":"J. Hepatol."},{"key":"75422_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02238-5","volume":"24","author":"C Li","year":"2025","unstructured":"Li, C. et al. Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARalpha-mediated fatty acid oxidation. Mol. Cancer 24, 34 (2025).","journal-title":"Mol. Cancer"},{"key":"75422_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49059-6","volume":"15","author":"X Tang","year":"2024","unstructured":"Tang, X. et al. Glycolysis inhibition induces anti-tumor central memory CD8(+)T cell differentiation upon combination with microwave ablation therapy. Nat. Commun. 15, 4665 (2024).","journal-title":"Nat. Commun."},{"key":"75422_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101415","volume":"5","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma. Cell Rep. Med. 5, 101415 (2024).","journal-title":"Cell Rep. Med."},{"key":"75422_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.canlet.2021.06.001","volume":"518","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation. Cancer Lett. 518, 23\u201334 (2021).","journal-title":"Cancer Lett."},{"key":"75422_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101128","volume":"4","author":"GP Zhang","year":"2023","unstructured":"Zhang, G. P. et al. Mechanical confinement promotes heat resistance of hepatocellular carcinoma via SP1\/IL4I1\/AHR axis. Cell Rep. Med. 4, 101128 (2023).","journal-title":"Cell Rep. Med."},{"key":"75422_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13046-023-02716-y","volume":"42","author":"ZR Shi","year":"2023","unstructured":"Shi, Z. R. et al. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation. J. Exp. Clin. Cancer Res. 42, 133 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"75422_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cmet.2023.04.017","volume":"35","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8(+) T cells in the tumor microenvironment. Cell Metab. 35, 961\u2013978 e910 (2023).","journal-title":"Cell Metab."},{"key":"75422_CR24","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1016\/j.molcel.2024.07.021","volume":"84","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z., Yang, Y., Chen, Y., Su, J. & Du, W. Malic enzyme 2 maintains metabolic state and anti-tumor immunity of CD8(+) T cells. Mol. Cell 84, 3354\u20133370 e3357 (2024).","journal-title":"Mol. Cell"},{"key":"75422_CR25","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/HEP.0000000000000962","volume":"81","author":"Q Liu","year":"2025","unstructured":"Liu, Q. et al. Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC. Hepatology 81, 1164\u20131180 (2025).","journal-title":"Hepatology"},{"key":"75422_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41565-024-01803-1","volume":"20","author":"J Qin","year":"2025","unstructured":"Qin, J. et al. Targeted intervention in nerve-cancer crosstalk enhances pancreatic cancer chemotherapy. Nat. Nanotechnol. 20, 311\u2013324 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"75422_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121938","volume":"292","author":"J Zang","year":"2023","unstructured":"Zang, J. et al. Dynamic tagging to drive arginine nano-assembly to metabolically potentiate immune checkpoint blockade therapy. Biomaterials 292, 121938 (2023).","journal-title":"Biomaterials"},{"key":"75422_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202414365","volume":"36","author":"X Li","year":"2024","unstructured":"Li, X. et al. Enhancing radiofrequency ablation for hepatocellular carcinoma: nano-epidrug effects on immune modulation and antigenicity restoration. Adv. Mater. 36, e2414365 (2024).","journal-title":"Adv. Mater."},{"key":"75422_CR29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41565-025-01909-0","volume":"20","author":"X Pan","year":"2025","unstructured":"Pan, X. et al. Nanoinducer-mediated mitochondria-selective degradation enhances T cell immunotherapy against multiple cancers. Nat. Nanotechnol. 20, 947\u2013958 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"75422_CR30","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41565-025-01952-x","volume":"20","author":"Q You","year":"2025","unstructured":"You, Q. et al. A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy. Nat. Nanotechnol. 20, 1298\u20131311 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"75422_CR31","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41565-024-01769-0","volume":"19","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR-Cas gene editing. Nat. Nanotechnol. 19, 1869\u20131879 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"75422_CR32","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41591-024-02894-y","volume":"30","author":"M Yarchoan","year":"2024","unstructured":"Yarchoan, M. et al. Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1\/2 trial. Nat. Med. 30, 1044\u20131053 (2024).","journal-title":"Nat. Med."},{"key":"75422_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202502940","volume":"37","author":"R Niu","year":"2025","unstructured":"Niu, R. et al. Spatiotemporal charging single-atom nanozymes activated pyroptosis for antitumor immunotherapy via bioorthogonal disruption of succination and reinvigorating T lymphocytes. Adv. Mater. 37, e2502940 (2025).","journal-title":"Adv. Mater."},{"key":"75422_CR34","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1053\/j.gastro.2004.09.031","volume":"127","author":"WH Hayden","year":"2004","unstructured":"Hayden, W. H. & Gerald, D. D. 3rd Thermal ablation for hepatocellular carcinoma. Gastroenterology 127, S167\u2013S178 (2004).","journal-title":"Gastroenterology"},{"key":"75422_CR35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","volume":"63","author":"B Jordi","year":"2014","unstructured":"Jordi, B., Gregory, J. G. & Vincenzo, M. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 63, 844\u2013855 (2014).","journal-title":"Gut"},{"key":"75422_CR36","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).","journal-title":"Science"},{"key":"75422_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"SW Patrick","year":"2012","unstructured":"Patrick, S. W. & Craig, B. T. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21, 297\u2013308 (2012).","journal-title":"Cancer Cell"},{"key":"75422_CR38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2212178119","volume":"119","author":"N Dirckx","year":"2022","unstructured":"Dirckx, N. et al. A specialized metabolic pathway partitions citrate in hydroxyapatite to impact mineralization of bones and teeth. Proc. Natl. Acad. Sci. USA 119, e2212178119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75422_CR39","doi-asserted-by":"publisher","first-page":"156417","DOI":"10.1016\/j.metabol.2025.156417","volume":"174","author":"L Li","year":"2026","unstructured":"Li, L. et al. Hepatic aconitase 1 redirects citrate flux to suppress lipogenesis and ameliorate hypercholesterolemia. Metab.-Clin. Exp. 174, 156417 (2026).","journal-title":"Metab.-Clin. Exp."},{"key":"75422_CR40","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1038\/s41467-025-62103-3","volume":"16","author":"N Yehoshua","year":"2025","unstructured":"Yehoshua, N. et al. Regulatory interaction between metabolite transporters coordinates glucose and exometabolite fluxes to drive bioenergetics. Nat. Commun. 16, 6819 (2025).","journal-title":"Nat. Commun."},{"key":"75422_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.semcancer.2021.07.014","volume":"86","author":"M Regimbeau","year":"2022","unstructured":"Regimbeau, M. et al. Heat shock proteins and exosomes in cancer theranostics. Semin. Cancer Biol. 86, 46\u201357 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"75422_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202303253","volume":"19","author":"H Du","year":"2023","unstructured":"Du, H. et al. Detachable MOF-based core\/shell nanoreactor for cancer dual-starvation therapy with reversing glucose and glutamine metabolisms. Small 19, e2303253 (2023).","journal-title":"Small"},{"key":"75422_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45473-y","volume":"15","author":"L Jia","year":"2024","unstructured":"Jia, L. et al. Porphyromonas gingivalis aggravates colitis via a gut microbiota-linoleic acid metabolism-Th17\/Treg cell balance axis. Nat. Commun. 15, 1617 (2024).","journal-title":"Nat. Commun."},{"key":"75422_CR44","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41589-022-01017-3","volume":"18","author":"SA Lim","year":"2022","unstructured":"Lim, S. A., Su, W., Chapman, N. M. & Chi, H. Lipid metabolism in T cell signaling and function. Nat. Chem. Biol. 18, 470\u2013481 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"75422_CR45","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.cmet.2025.03.004","volume":"37","author":"EM P\u00e5lsson-McDermott","year":"2025","unstructured":"P\u00e5lsson-McDermott, E. M. & O\u2019Neill, L. A. J. Gang of 3: how the Krebs cycle-linked metabolites itaconate, succinate, and fumarate regulate macrophages and inflammation. Cell Metab. 37, 1049\u20131059 (2025).","journal-title":"Cell Metab."},{"key":"75422_CR46","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cmet.2023.05.005","volume":"35","author":"L Nezi","year":"2023","unstructured":"Nezi, L. & Manzo, T. Fumarate disarms CD8(+) T cells against cancer. Cell Metab. 35, 907\u2013909 (2023).","journal-title":"Cell Metab."},{"key":"75422_CR47","doi-asserted-by":"publisher","first-page":"2401359","DOI":"10.1002\/adfm.202401359","volume":"34","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. Biomimetic MOF-based nano-immunoactivator via disruption of ion homeostasis for strengthened tumor microwave-immunotherapy. Adv. Funct. Mater. 34, 2401359 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"75422_CR48","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1021\/acsami.4c18641","volume":"17","author":"SM Li","year":"2025","unstructured":"Li, S. M. et al. Synchronous interference of dual metabolic pathways mediated by HS Gas\/GOx for augmenting tumor microwave thermal therapy. ACS Appl. Mater. Interfaces 17, 4595\u20134607 (2025).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"75422_CR49","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jconrel.2022.11.004","volume":"352","author":"ZG Zhou","year":"2022","unstructured":"Zhou, Z. G. et al. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy. J. Control. Release 352, 793\u2013812 (2022).","journal-title":"J. Control. Release"},{"key":"75422_CR50","doi-asserted-by":"publisher","first-page":"170334","DOI":"10.1016\/j.cej.2025.170334","volume":"525","author":"YK Chen","year":"2025","unstructured":"Chen, Y. K. et al. Self-amplifying cryo-immunotherapy enabled by Ga-MOF nanoplatform for metastatic lung cancer. Chem. Eng. J. 525, 170334 (2025).","journal-title":"Chem. Eng. J."},{"key":"75422_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403858","volume":"11","author":"L He","year":"2024","unstructured":"He, L. et al. Tumor microenvironment-responsive nanocapsule delivery CRISPR\/Cas9 to reprogram the immunosuppressive microenvironment in hepatoma carcinoma. Adv. Sci. 11, e2403858 (2024).","journal-title":"Adv. Sci."},{"key":"75422_CR52","doi-asserted-by":"publisher","first-page":"102294","DOI":"10.1016\/j.mtbio.2025.102294","volume":"35","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Simultaneous induction of immunogenic cell death and PD-L1 downregulation by bufalin-based nanovaccines for potentiate HCC immunotherapy. Mater. Today Bio. 35, 102294 (2025).","journal-title":"Mater. Today Bio."},{"key":"75422_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02808-7","volume":"22","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Ferroptosis-inducing nanomedicine and targeted short peptide for synergistic treatment of hepatocellular carcinoma. J. Nanobiotechnol. 22, 533 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"75422_CR54","doi-asserted-by":"publisher","first-page":"12679","DOI":"10.1021\/acsnano.0c01453","volume":"14","author":"T Zhou","year":"2020","unstructured":"Zhou, T. et al. A hepatocellular carcinoma targeting nanostrategy with hypoxia-ameliorating and photothermal abilities that, combined with immunotherapy, inhibits metastasis and recurrence. ACS Nano 14, 12679\u201312696 (2020).","journal-title":"ACS Nano"},{"key":"75422_CR55","first-page":"1303","volume":"77","author":"R Giavazzi","year":"1986","unstructured":"Giavazzi, R., Jessup, J. M., Campbell, D. E., Walker, S. M. & Fidler, I. J. Experimental nude mouse model of human colorectal cancer liver metastases. J. Natl. Cancer Inst. 77, 1303\u20131308 (1986).","journal-title":"J. Natl. Cancer Inst."},{"key":"75422_CR56","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/2159-8290.CD-17-0935","volume":"8","author":"BJ Drapkin","year":"2018","unstructured":"Drapkin, B. J. et al. Genomic and functional fidelity of small cell lung cancer patient-derived xenografts. Cancer Discov. 8, 600\u2013615 (2018).","journal-title":"Cancer Discov."},{"key":"75422_CR57","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","volume":"9","author":"M Ruiz de Galarreta","year":"2019","unstructured":"Ruiz de Galarreta, M. et al. beta-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma. Cancer Discov. 9, 1124\u20131141 (2019).","journal-title":"Cancer Discov."},{"key":"75422_CR58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui, S. et al. Glucose feeds the TCA cycle via circulating lactate. Nature 551, 115\u2013118 (2017).","journal-title":"Nature"},{"key":"75422_CR59","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1021\/acs.jcim.5b00690","volume":"56","author":"X Wang","year":"2016","unstructured":"Wang, X., Pan, C., Gong, J., Liu, X. & Li, H. Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of Drugs. J. Chem. Inf. Model. 56, 1175\u20131183 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"75422_CR60","doi-asserted-by":"publisher","first-page":"W609","DOI":"10.1093\/nar\/gkq300","volume":"38","author":"X Liu","year":"2010","unstructured":"Liu, X. et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res. 38, W609\u2013W614 (2010).","journal-title":"Nucleic Acids Res."},{"key":"75422_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","volume":"172","author":"R Su","year":"2018","unstructured":"Su, R. et al. R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling. Cell 172, 90\u2013105 e123 (2018).","journal-title":"Cell"},{"key":"75422_CR62","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41589-020-0601-2","volume":"16","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. NADP modulates RNA m(6)A methylation and adipogenesis via enhancing FTO activity. Nat. Chem. Biol. 16, 1394\u20131402 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"75422_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27833-0","volume":"13","author":"Z Qi","year":"2022","unstructured":"Qi, Z. et al. Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kalpha\/beta\/delta treatment. Nat. Commun. 13, 182 (2022).","journal-title":"Nat. Commun."},{"key":"75422_CR64","unstructured":"CNCB\u2013NGDC Members and Partners. Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2026. Nucleic Acids Res. 54, D28\u2013D47 (2026)."},{"key":"75422_CR65","doi-asserted-by":"publisher","first-page":"qzaf072","DOI":"10.1093\/gpbjnl\/qzaf072","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang, S. et al. The GSA family in 2025: a broadened sharing platform for multi-omics and multimodal data. Genomics Proteom. Bioinforma. 23, qzaf072 (2025).","journal-title":"Genomics Proteom. Bioinforma."},{"key":"75422_CR66","doi-asserted-by":"publisher","first-page":"D459","DOI":"10.1093\/nar\/gkaf1146","volume":"54","author":"EW Deutsch","year":"2026","unstructured":"Deutsch, E. W. et al. The ProteomeXchange consortium in 2026: making proteomics data FAIR. Nucleic Acids Res 54, D459\u2013D469 (2026).","journal-title":"Nucleic Acids Res"},{"key":"75422_CR67","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553 (2025).","journal-title":"Nucleic Acids Res."},{"key":"75422_CR68","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1074\/mcp.O115.050229","volume":"15","author":"Y Perez-Riverol","year":"2016","unstructured":"Perez-Riverol, Y. et al. PRIDE inspector toolsuite: moving toward a universal visualization tool for proteomics data standard formats and quality assessment of proteomexchange datasets. Mol. Cell Proteom. 15, 305\u2013317 (2016).","journal-title":"Mol. Cell Proteom."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75422-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75422-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75422-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:04:00Z","timestamp":1787101440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75422-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75422"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75422-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8648"}}